NLRP3 and Sepsis: Studies have also suggested that the administration of inhibitors of NLRP3/caspase-1 pathway-mediated pyroptosis (e.g., MC950, melatonin) is protective against sepsis-associated encephalopathy, spinal cord injury, and motor neuron damage in rats [60].